Independent Medical Alliance Releases Third Edition of the Journal of Independent Medicine

Latest Volume Amplifies Calls for Scientific Integrity Amid Government Scrutiny of Advisory Panels and Institutional Bias

WASHINGTON, Aug. 12, 2025 /PRNewswire/ -- The Independent Medical Alliance (IMA) today announced the publication of Volume 1, Issue No. 3 of the Journal of Independent Medicine, the organization's peer-reviewed, double-blind scientific journal dedicated to restoring integrity, transparency, and public trust in medicine. The new issue arrives as the federal government continues to reassess conflicts of interest within its health agencies and advisory committees—an inflection point that underscores the need for rigorous, independent scientific platforms.

"We launched this journal to give voice to researchers and clinicians who were sidelined for speaking scientific truth during a time of global crisis," said Dr. Joseph Varon, Editor-in-Chief of the Journal of Independent Medicine and President of IMA. "As the administration reevaluates who sits on its advisory boards and begins rooting out embedded financial conflicts, the need for unbiased, transparent science has never been greater. This journal exists to meet that moment."

The Journal of Independent Medicine has quickly become a respected outlet for timely, provocative, and underreported research—free from pharmaceutical influence or political gatekeeping. In light of the U.S. Department of Justice's ongoing inquiries into editorial bias in leading medical journals, the Journal of Independent Medicine has distinguished itself as a trustworthy alternative, welcoming contrarian viewpoints and rigorous critique.

"This isn't just a journal—it's a course correction," added Dr. Varon. "We are building the infrastructure for honest medicine, piece by piece, and publishing the kind of research that can help policymakers, practitioners, and the public make truly informed decisions."

Featured Articles in Volume 1, Issue No. 3
Review Articles

• Nucleoside-Modified RNA and Lipid Nanoparticles – A Review for Lay People (Jessica Rose)
  A clear, accessible breakdown of modRNA–LNP technology and the safety signals raised by global pharmacovigilance systems.
• COVID-19 mRNA-Induced "Turbo Cancers" (Paul Marik & Justus Hope)
  A review of the aggressive cancer patterns reported post-vaccination and the plausible biological mechanisms behind them.
• Built Different: Functional Sleep Deprivation and the Elite Physician Phenotype (Joseph Varon)
  A review exploring whether some physicians function optimally under sleep deprivation—and the risks of normalizing this phenomenon.
• Pre-Existing Immunity to COVID-19 – Part 1 (Rachel Nicoll)
  A comprehensive look at cross-reactive immunity to SARS-CoV-2 from prior coronavirus exposures.
• The Great PCR and HPAI Mistake (Roger S. Meacock)
  A veterinary case study revealing the misuse of PCR testing in diagnosing avian flu, with broader implications for over-testing.

Original Articles

• Metacritique of Influential Studies Purporting COVID-19 Vaccine Successes: Part 2 (Raphael Lataster)
  A deconstruction of statistical and methodological flaws in a major modeling study used to justify universal mRNA vaccination.
• COVID Skeptics Were Right: U.S. Government Report Vindicates Suppressed Narratives (Raphael Lataster & Robert W. Malone)
  A summary and contextual analysis of the House Select Subcommittee's findings—many of which affirm formerly censored scientific positions.

Medicolegal

• Reclaiming Health with the ACES Model (Jingduan Yang)
  A white paper introducing a whole-person health framework integrating anatomy, chemistry, energy, and soul for systemic medical reform.

Letters to the Editor

• Mortality Claims About COVID-19 Vaccinations (Paul Zarembka)
  A critique of vaccine mortality data and the importance of transparent interpretation amidst conflicting claims.
• Multiple Sclerosis Remission Is Possible (Bob Sblendorio & Christina Kiening)
  A patient's testimony on achieving remission through the Coimbra Protocol and a call for medical education on vitamin D therapy.

This issue—and all past issues—are available free of charge at www.JIndepMed.org.

About the Journal of Independent Medicine
The Journal of Independent Medicine, published quarterly by the Independent Medical Alliance™, is a double-blind peer-reviewed journal that serves as a sanctuary for scientific truth. Free from pharmaceutical funding and political bias, it is committed to publishing research that prioritizes patients over profits and rigor over ideology. The journal features contributions from a global editorial board of 43 experts representing 17 countries and dozens of specialties.

For more information, visit www.JIndepMed.org.

About the Independent Medical Alliance (IMA)
The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, scientists, and other healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization's mission is driven by Honest Medicine™, prioritizing patients above profits and emphasizing long-term wellness and disease prevention by empowering both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system. IMA and IMA Action, the 501 (c) (4) advocacy arm of IMA, were a powerful presence during the RFK Jr. confirmation hearings, mobilizing grassroots activists in Washington, D.C., and nationwide.

Media Contact
Lynne Kristensen
[email protected] 

SOURCE Independent Medical Alliance